Skip to content

Perioperative Gabapentin for Prevention and Attenuation of Postoperative Shoulder Pain After Laparoscopic ovarian cystectomy

Perioperative Gabapentin for Prevention and Attenuation of Postoperative Shoulder Pain After Laparoscopic ovarian cystectomy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000269932
Enrollment
40
Registered
2011-03-14
Start date
2009-09-23
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Background: Shoulder pain after laparoscopic procedures is a frequent complication encountered in Gynecology ward. It is provoked by irritation or injury of the phrenic nerve at the diaphragm surface during CO2 pneumoperitoneum. Several treatments have been proposed to reduce post laparoscopic shoulder pain. Gabpantin is one of these treatments which was effective in post laparoscopic pain reduction. The purpose of this study is to evaluate the efficacy of perioperative Gabapentin in preventing and attenuating PLSP after laparoscopic ovarian cystectomy. Material and methods: This is a prospective, randomized, double-blind study. 40 patients undergoing elective laparoscopic ovarian cystectomy in Women hospital Tehran University of medical science were enrolled in our study from April 2008 to march 2009 according to the inclusion and exclusion criteria. The control group received oral placebo capsules and case group 600 mg Gabapentin 0.5 h before surgery. The intensity of post laparoscopic shoulder pain (PLSP) was recorded by patient using a visual analogue scale (VAS) 2, 6, 12 hours post anesthetic recovery. Results: There was no statistical significant difference between 2 groups in clinical characteristics. Duration of laparoscopy was similar in Gabapentin and placebo group. The frequency of post laparoscopic shoulder pain (PLSP) was (45%) in Gabapentin group and (75%) in placebo group (p=0.05) Post laparoscopic shoulder pain (PLSP) intensity in Gabapentin group was significantly lower than placebo group (p=0.004). We did not observe any adverse effect. Conclusion: 600mg Gabapentin as premedication was significantly effective in reducing post laparoscopic shoulder pain intensity after gynecologic laparoscopy compared with placebo without any adverse effect.

Interventions

Drug : Gabapentin 600mg oral cap Gabapentin as premedication only once before laparascopy premedication : treatment occurs before the elective laparoscopic ovarian cystectomy

Sponsors

Tehran University of Medical Science
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

patients with 1- aged between 18 and70 2- of ASA (American Society of Anesthesia) physical status I–II 3- undergoing elective laparoscopic ovarian cystectomy were enrolled in our study

Exclusion criteria

1) hypersensitivity to any study drugs 2) serious organ disease/dysfunction 3) persistent preoperative pain 4) daily intake, or intake 48 h preoperatively, of any analgesic 5) alcohol/substance abuse 6) a major psychiatric disorder 7) a bleeding disorder 8) peptic ulcer disease 9) asthma/COPD 10) a seizure disorder 11) pervious abdominal surgery

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026